A mitomycin-N6-deoxyadenosine adduct isolated from DNA

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Cancer Research

Background:

• Mitomycin C (MC) is a chemotherapeutic agent known to form DNA adducts, primarily at guanine residues.
• Understanding the full spectrum of MC-DNA adducts is crucial for predicting its efficacy and toxicity.

Purpose of the Study:

• To identify and characterize novel DNA adducts formed by mitomycin C (MC).
• To investigate the sequence specificity and structural features of MC adducts with adenine.
• To compare in vitro findings with in vivo observations of MC adducts in cancer cells.

Main Methods:

• Isolation and structural elucidation of a novel N6-deoxyadenosine adduct of MC (adduct 8) using spectroscopic and mass spectrometry techniques.
• Synthesis of oligonucleotide probes to study the specificity of MC alkylation at adenine sites.
• Enzymatic digestion and High-Performance Liquid Chromatography (HPLC) analysis to quantify adduct formation.
• Comparison of HPLC elution profiles with previously identified in vivo adducts.

Main Results:

• The first N6-deoxyadenosine adduct of mitomycin C (adduct 8) was isolated and structurally characterized.
• Adduct formation at adenine sites was favored in (A)n sequences over (AT)n sequences and occurred preferentially in duplex DNA.
• Monofunctional alkylation at adenine sites was observed, with an adenine-to-guanine alkylation ratio of 0.03 in calf thymus DNA, indicating adduct 8 is a minor adduct in this system.
• The HPLC elution time of adduct 8 matched a previously detected major unknown MC adduct in vivo.

Conclusions:

• Mitomycin C can form adducts with adenine, expanding the known adduct profile beyond guanine.
• Adduct 8, although a minor product in vitro, may represent a significant adduct formed in vivo, potentially contributing to the therapeutic or toxic effects of mitomycin C.
• Further comparative studies are needed to confirm the identity of adduct 8 with the major in vivo adduct.